TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Trimethoprim Sulfate And Polymyxin B Sulfate patents expire, and when can generic versions of Trimethoprim Sulfate And Polymyxin B Sulfate launch?
Trimethoprim Sulfate And Polymyxin B Sulfate is a drug marketed by Bausch And Lomb, Epic Pharma Llc, Sandoz, and Somerset Theraps Llc. and is included in four NDAs.
The generic ingredient in TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE?
- What are the global sales for TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE?
- What is Average Wholesale Price for TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE?
Summary for TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 11 |
DailyMed Link: | TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE at DailyMed |